Ottadim T 250mg/31.25mg Injection
Marketer
Kestrel Lifesciences
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Ottadim T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under a physician's guidance; adherence to the prescribed schedule is crucial. Complete the entire course, even with symptom improvement; premature cessation can compromise efficacy. Typical mild adverse effects may include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms promptly. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor treatment effectiveness.
Primary Ingredients of Ottadim T 250mg/31.25mg Injection
The provided text is "undefined," which has no meaning and therefore cannot be rephrased.
Uses of Ottadim T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ottadim T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ottadim T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Ottadim T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ottadim T 250mg/31.25mg Injection works:
Ceftazidime/Tazobactam injection (Ottadim T 250mg/31.25mg) unites two active agents to combat bacterial infections. Ceftazidime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftazidime's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ottadim T 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ottadim T 250mg/31.25mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Ottadim T 250mg/31.25mg Injection safely. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The injection Ottadim T 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
The injectable medication, Ottadim T 250mg/31.25mg, requires careful administration in individuals with impaired kidney function. Dosage modification for Ottadim T 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with significant hepatic impairment should exercise caution when using Ottadim T 250mg/31.25mg Injection. Dosage modification for Ottadim T 250mg/31.25mg Injection may be necessary. Medical advice is recommended.
What if you forget to take Ottadim T 250mg/31.25mg Injection :
Should you inadvertently skip a dose of Ottadim T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Ottadim T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently